Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Indian Americans To Urge Trump For Sanctions Against Bangladesh

Indian Americans are working to reach out to the new Trump administration and the Congress next year to seek action against the Bangladeshi ...